genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 4.390
0.00 (0.00%)
At close: Jan 23, 2026
genXone Company Description
genXone S.A. operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.
The company operates in the field of molecular genetics and bioinformatics. It also develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture.
genXone S.A. was incorporated in 2018 and is headquartered in Suchy Las, Poland.
genXone S.A.
| Country | Poland |
| Founded | 2018 |
| Industry | Pharmaceuticals |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Michal Kaszuba |
Contact Details
Address: ul. Kobaltowa 6 Suchy Las, 60-002 Poland | |
| Phone | 48 888 60 23 08 |
| Website | genxone.eu |
Stock Details
| Ticker Symbol | GX1 |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLGENXN00013 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Michal Kaszuba | Chief Executive Officer |